期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Clinical and Investigative Medicine LetPub Score 5.0
50 ratings
Rate
Reputation 6.4 Influence 3.5 Speed 7.0 | ||||||||||||||||
期刊簡稱 | CLIN INVEST MED | ||||||||||||||||
ISSN | 0147-958X | ||||||||||||||||
E-ISSN | 1488-2353 | ||||||||||||||||
h-index | 43 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://cimonline.ca/index.php/cim | ||||||||||||||||
在線稿件提交 | https://cimonline.ca/index.php/cim/information/authors | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | The Canadian Society for Clinical Investigation | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1978 | ||||||||||||||||
每年文章數 | 9每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0147-958X%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Clinical and Investigative Medicine] 的評論 | 撰寫評論 |
作者: 东风谷松伟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-01 09:19:29 評論於 No translation available(0) 讚! | 东风谷松伟 |
作者: 平原天逸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-25 18:00:51 評論於 Will this magazine send a confirmation letter?(0) 讚! | 平原天逸 |
作者: 平原天逸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-20 08:51:14 評論於 Has anyone delivered this magazine?(0) 讚! | 平原天逸 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:18:55 評論於 The Science Citation Index (SCI), abbreviated as SCI, was founded in 1957 by the Institute for Scientific Information (ISI) in Philadelphia, USA. It is a citation database published by the ISI in 1961. SCI, Engineering Index (EI), and Conference Proceedings Citation Index (ISTP) are the three most famous scientific literature retrieval systems in the world. They are internationally recognized as the main tools for scientific statistics and evaluation, with SCI being the most important(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:43:44 評論於 ORCID is a unique identifier for open scholars (Researcher and Contributor ID). The ORCID ID is the unique and persistent academic identity of contributors, which distinguishes authors from other researchers and records all relevant research activities of the author. It is necessary to log in to each author's account and then associate it in the account information section(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:46:44 評論於 How to add ORCID iD if it is not provided when the article is published?(0) 讚! | Oswald Edie |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 19:53:33 評論於 What is SCI?(0) 讚! | 上清雨真 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 09:17:00 評論於 Oh no! Falling so badly, it's embarrassing to be seen, what a trashy magazine(0) 讚! | 凌霄高洁 |
作者: 蒂龙斯特拉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-17 09:56:15 評論於 Review speed: 6.0 | Submission success rate: 25.0 Experience sharing: It feels like there is not much difference between whether the reviewer provides comments or not. The review process takes too long, almost half a year, and the submission is still rejected(0) 讚! | 蒂龙斯特拉 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-23 17:33:08 評論於 What era is it now, and the submission method is actually to send it to the editor-in-chief's email(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-23 10:07:13 評論於 Submission Procedure.. Manuscripts, including Tables, Figures and a Covering Letter should be submitted via email directly to the Editor: Dr. Jonathan Angel, jangel@ohri.ca. I'm speechless.. still submitting like this(0) 讚! | 凌霄高洁 |
作者: Werner Longfellow 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-01-31 10:50:08 評論於 It's getting slower and slower, sweat(0) 讚! | Werner Longfellow |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-11-15 10:30:51 評論於 The number of submissions received each year continues to increase, resulting in a relatively high rejection rate. The average review time is approximately 2-3 months(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us